A Comparison of Exparel Local Anesthetic in Total Knee Arthroplasty (TKA) Patients

Withdrawn before enrolling · Phase 4

Conditions studied: Osteoarthritis, Knee, Arthroplasty, Replacement, Knee

In brief

This is a prospective, single-center, single-blinded, randomized, case-control study. The study is conducted by a single investigator at an orthopedic surgery institute, with a minimum 6 week post operative follow-up period of TKA patients who receive Exparel compared with the surgeon's standard method (detailed below) for pain management intraoperatively.

Key facts

Study ID
NCT02765815
Run by
Holy Cross Hospital, Florida
People needed
0
Starts
2016-02-01
Expected to finish
2017-01-01
Last updated by the study team
2017-08-09

Who can join

Age: 18 and older, up to 88. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.